We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Novel immunotherapeutic approaches to the treatment of urothelial carcinoma.
- Authors
Muthigi, Akhil; George, Arvin K.; Brancato, Sam J.; Agarwal, Piyush K.
- Abstract
Immunotherapy has long played a role in urothelial cancers with the use of bacille Calmette Guérin (BCG) being a mainstay in the treatment of nonmuscle invasive bladder cancer. Novel therapeutic approaches have not significantly impacted mortality in this population and so a renaissance in immunotherapy has resulted. This includes recombinant BCG, oncolytic viruses, monoclonal antibodies, vaccines, and adoptive T-cell therapy. Herein, we provide a review of the current state of the art and future therapies regarding immunotherapeutic strategies for urothelial carcinoma.
- Publication
Therapeutic Advances in Urology, 2016, Vol 8, Issue 3, p203
- ISSN
1756-2872
- Publication type
Article
- DOI
10.1177/1756287216628784